CLDF Title
Contact Us | Bookmark
HBV HE HCC HCV NASH-NAFLD
About CLDF Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
EASL 2016     Banner2   IC-Hep
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Gilead escapes liability in hepatitis C patent fight with Merck
06-07-2016
Indomethacin may curb pancreatitis after cholangiopancreatography
06-03-2016
Anticoagulant improves outcome of incidentally detected splanchnic vein thrombosis
06-02-2016
Burden of pricey hepatitis C drugs heaviest in eastern Europe
05-31-2016
View Complete News Library
 
 
September 9-11
10th Annual ILCA (INTERNATIONAL LIVER CANCER ASSOCIATION) Conference
Vancouver, Canada
October 14-19
ACG 2016 Annual Scientific Meeting and Postgraduate Course
Las Vegas, Nevada
November 11-15
AASLD 2016
Boston, Massachusetts
View all Congresses
 
 
 
  Line  
  Featured Abstracts          
 
The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals?
 
Changes in Liver Volume in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy
 
Hepatotoxicity and Potential Drug Interaction with Ledipasvir/Sofosbuvir In HIV/HCV Infected Patients
 
A systematic review of community based hepatitis C treatment
 
Association of Hepatitis C Virus With Alcohol Use Among U.S. Adults: NHANES 2003-2010
 
Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort
 
 
Transmission of blood-borne pathogens in US dental health care settings: 2016 Update
 
Overview of hepatitis B viral replication and genetic variability
 
Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy
 
Are current screening protocols for chronic hepatitis B virus infection adequate?
 
Valproic acid-induced hyperammonemia and minimal hepatic encephalopathy prevalence among psychiatric inpatients
 
Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia
 
 
A low-cost, user-friendly electroencephalographic recording system for the assessment of hepatic encephalopathy
 
Techniques for Transjugular Intrahepatic Portosystemic Shunt Reduction and Occlusion
 
The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma
 
Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
 
Current Status of Liver Allocation in the United States
 
Randomized, Open-Label Phase 2 Study Comparing Frontline Dovitinib vs Sorafenib in Patients With Advanced Hepatocellular Carcinoma
 
 
          View All Abstracts  
  Line  
                     
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Telewebs
Webcasts
Slide Library
Abstract Library
 
 
NASH/NAFLD
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
         
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2016 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.